This community includes publications, datasets and other published material developed in the context of the INTEREPT-MDS project. INTERCEPT-MDS brings together 10 European public and private institutions in a European network of experts in leukaemia, epigenetics and single-cell genomics. Through a multidisciplinary and multisectoral approach, INTERCEPT-MDS trains 12 PhD fellows in the novel field of disease interception: treating a disease before it fully develops by removing altered cells.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 953407.
Disclaimer: Communication activities reflect only the author's view and the Research Executive Agency (REA) and European Commission (EC) are not responsible for any use that may be made of the information it contains.
Project website: www.intercept-mds.eu
Social media: Twitter (https://twitter.com/intercept_mds); Instagram (https://www.instagram.com/intercept_mds/); LinkedIn (https://es.linkedin.com/company/intercept-mds-itn)